The Acne Protocol: 2-Step Anti-Acne System

Clear Skin, Clinically Proven: Your New Acne-Fighting Ritual

• 89% reduction in acne bacteria in 28 days
• 76% less oiliness in just 1 week
• 78% reduction in blackheads in 8 weeks
• Fades post-acne marks without peeling or stinging

A dermatologist-formulated 2-step system that tackles breakouts, excess oil, clogged pores, and post-acne marks — all while protecting your skin barrier.

• Step 1: The Tea Tree Cleanser
  Purifies, calms, and controls oil with natural tea tree & sage
• Step 2: The 2% Salicylic Acid Exfoliator
  Deep pore-cleansing action with added hydration and barrier support

Key Benefits

1. Total Acne Control: Reduces acne bacteria by 89% in 28 days
2. Balanced Oil Production: Less shine, fewer clogged pores
3. Smoother Texture: Gently exfoliates to fade marks and refine skin
4. Hydration First: Non-drying formulas with hyaluronic acid + D-Panthenol
5. Clean Ingredients: Fragrance-free, no harsh irritants, botanically enriched
6. Dermatologist Approved: Safe for daily use, even on sensitive skin

Now, say goodbye to the guessing game of piecing together skincare products. The Acne Protocol is your go-to system for visible results—designed to calm inflammation, clear out pores, and reveal skin you’ll feel proud of.

Whether you're battling oily breakouts or stubborn marks, this 2-step ritual is your daily reset for a clearer, calmer complexion.

Start your 12-week skin transformation with The Acne Protocol. Real results. No compromise.

Clears pores, reduces blackheads, and prevents breakouts by dissolving oil, debris, and dead skin—without irritation.

• Salicylic Acid (2%) – Penetrates pores to unclog and reduce oil
• Lavender Extract – Calms inflammation and redness
• Hyaluronic Acid – Deep hydration without heaviness
• D-Panthenol – Strengthens the skin barrier and promotes healing

Oily, acne-prone, and combination skin. Especially effective for blackheads, post-acne marks, and rough texture.

• 78% reduction in blackheads within 8 weeks
• Matches prescription-level performance with better tolerance
  (Zheng et al., 2019 – PubMed)